Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Baerum Cardiovascular Diabetes (ABCD) cohort study

Conclusions:
IL-6 and actA may provide prognostic information on CV events and mortality in T2D beyond conventional CV risk factors.Trial registrationClinicalTrials.gov: NCT00133718

Source: Cardiovascular Diabetology - August 30, 2013 Category: Cardiology Authors: Anne Pernille OfstadLars GullestadElsa OrvikSvend AakhusKnut EndresenThor UelandPål AukrustMorten FagerlandKåre BirkelandOdd Erik Johansen Source Type: research